Why the study?
Microcatheters are essential for CTO PCI, and several new devices have recently been introduced aiming to improve deliverability and resistance to deformation.
Recently developed microcatheters provide additional options for guidewire support during CTO PCI, but further clinical experience and comparative studies are required.
Answers are grounded in this paper and cite their sources.
May expand guidewire support options in CTO PCI; leaves open comparative effectiveness versus established devices.
Use of a microcatheter is essential for chronic total occlusion (CTO) percutaneous coronary intervention (PCI). Several microcatheters have recently been introduced in clinical practice aiming to improve deliverability and resistance to deformation. Areas covered: We review the technical characteristics of several new microcatheters (Mamba, Mamba Flex, Teleport Control, Teleport, Nhancer Rx, Sasuke, and ReCross) and compare them with existing microcatheters. Expert opinion: The recently developed microcatheters offer additional options for guidewire support during CTO PCI. Accumulation of clinical experience and performance of comparative effectiveness studies are needed for better understanding the role of these devices in contemporary CTO PCI.
No takes yet. Share an insight, caveat, or question.
Vemmou et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: